Ahn Byung-hoon "Because of Cough Medicine"... '3-Month Suspension from Competition'

Positive Doping Test in PGA Tour
8th Player Caught for Doping
Eligible to Compete from December 1

Byeonghun An has been suspended from competition for 3 months due to a violation of the anti-doping policy.

The PGA Tour announced on the 11th (local time), "Byeonghun An tested positive in a doping test because of a cough medicine he took in Korea, resulting in a sanction. The suspension period is 3 months starting from August 31." The PGA Tour stated, "The cough medicine Byeonghun An took contained a substance banned by the World Anti-Doping Agency (WADA)," and added, "Byeonghun An cooperated well with the doping test and accepted the sanction."

An Byeonghun

The sanction period is applied retroactively. He will be eligible to compete from December 1. Byeonghun An is the eighth player caught doping on the PGA Tour. The PGA Tour has enforced its doping policy since 2008. This is the first doping case in four years since Matt Every (USA) in 2019.

Byeonghun An posted on his social media, "I caught a cold in Korea last August," and "My cough symptoms worsened, so I took medicine, but carelessly did not properly check the ingredients of the medicine." He wrote, "The use of that medicine was solely for relieving cold symptoms and for no other purpose," and added, "I acknowledge my carelessness and take responsibility for my actions."

In the 2022/2023 PGA Tour season, Byeonghun An participated in 31 tournaments and tied for 2nd place at the Wyndham Championship last August. He is currently ranked 53rd in the world. He has not competed since the BMW Championship ended on August 21. Although suspended and unable to participate in the ongoing PGA Tour Fall Series, he is ranked 44th in the FedEx Cup standings and has secured his card for next year's regular tour.

This content was produced with the assistance of AI translation services.